Healthy Infants at Risk from Severe RSV Infections

Recent research has revealed that even healthy, full-term infants are at considerable risk of severe respiratory syncytial virus (RSV) infections, which can lead to intensive care admission or extended hospitalization. This finding is particularly concerning for babies during their first three months of life.

A comprehensive study conducted by researchers at the Karolinska Institutet in Sweden examined over 2.3 million children born between 2001 and 2022. The study, published in The Lancet Regional Health--Europe, aimed to identify risk factors associated with severe outcomes from RSV infections.

RSV is a prevalent cause of respiratory illness in young children, resulting in approximately 245,000 hospital admissions annually across Europe. While it is well established that premature infants and those with chronic health issues are at heightened risk for severe RSV illness, the extent of risk faced by otherwise healthy infants had not been fully understood prior to this study.

The analysis indicated that the majority of children requiring intensive care or prolonged hospitalization were previously healthy infants under three months of age. According to the study's lead researcher, it is essential for healthcare providers to recognize that healthy infants can be gravely affected by RSV.

Fortunately, advancements in preventive treatments have emerged. Starting September 10, 2025, all newborns in Sweden will be eligible for preventive antibody treatment during the RSV season. This medication functions similarly to a vaccine, providing protection against severe RSV infection for approximately six months.

The study also uncovered various risk factors associated with severe RSV outcomes. Among the 1.7% of children diagnosed with RSV infection, nearly 12% experienced severe illness. The average age of children who required intensive care was just under two months, with most lacking any underlying health issues.

Several significant risk factors were identified, including being born during winter months, having siblings aged 0-3 years, or being a twin, which increased the risk of severe illness threefold. Additionally, infants with low birth weights were found to have an almost fourfold increased risk, while those with preexisting medical conditions faced more than a fourfold increased risk of severe illness or death.

The research underlines that while preventive treatments have mainly targeted children with existing health issues, many previously healthy infants also require protection during RSV season. The inclusion of more infants in preventive measures is a positive development as healthcare strategies evolve.

This study was a collaborative effort involving researchers from the University of Helsinki and Helsinki University Hospital in Finland, emphasizing the importance of international research partnerships in addressing public health issues.